201
|
Liu Y, Cheng Y, Wang Q, Li K, Shi J, Wu L, Han B, Chen G, He J, Wang J, QIN H, Li X. 1787P Effect of anlotinib in advanced small cell lung cancer patients with pleural metastases/pleural effusion: A subgroup analysis from a randomized, double-blind phase II trial (ALTER1202). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1548] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
202
|
Jiang SW, Gao H, Wu L, Wang GW, Cen FL, Li JX, Feng C, Wen JM, Chen Y, He RL, Qiao K, Wang Y, Liu YX, Wang ZQ. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:580-586. [PMID: 32455515 DOI: 10.3760/cma.j.cn112148-20200304-00155] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyse the clinical history, laboratory tests and pathological data of a patient who suffered from novel coronavirus pneumonia(COVID-19) and provide reference for the clinical treatment of similar cases. Methods: Data of clinical manifestation, laboratory examination, bronchoscopy, echocardiography and cardiopulmonary pathological results were retrospectively reviewed in a case of COVID-19 with rapid exacerbation from mild to critical condition. Results: This patient hospitalized at day 9 post 2019 novel coronavirus(2019-nCoV) infection, experienced progressive deterioration from mild to severe at day 12, severe to critical at day 18 and underwent extracorporeal membrane oxygenation(ECMO) and continuous renal replacement therapy(CRRT) as well as heart lung transplantation during day 28-45 post infection, and died at the second day post heart and lung transplantation. The patient had suffered from hypertension for 8 years. At the early stage of the disease, his symptoms were mild and the inflammatory indices increased and the lymphocyte count decreased continuously. The patient's condition exacerbated rapidly with multi-organ infections, and eventually developed pulmonary hemorrhage and consolidation, pulmonary hypertension, right heart failure, malignant ventricular arrhythmias, liver dysfunction, etc. His clinical manifestations could not be improved despite viral RNAs test results became negative. The patient underwent lung and heart transplantation and finally died of multi organ failure at the second day post lung and heart transplantation. Pathological examination indicated massive mucus, dark red secretions and blood clots in bronchus. The pathological changes were mainly diffused pulmonary hemorrhagic injuries and necrosis, fibrosis, small vessel disease with cardiac edema and lymphocyte infiltration. Conclusions: The clinical course of severe COVID-19 can exacerbate rapidly from mild to critical with lung, liver and heart injuries.
Collapse
Affiliation(s)
- S W Jiang
- Department of Cardiology, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - H Gao
- Department of Cardiology, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - L Wu
- Department of Cardiology, Peking University First Hospital, Beijing 100034, China
| | - G W Wang
- Intensive Care Unit, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - F L Cen
- Intensive Care Unit, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - J X Li
- Intensive Care Unit, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - C Feng
- Department of Medical Ultrasonics, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - J M Wen
- Intensive Care Unit, Fuwai Hospital, Chinese Academy of Medical Sciences Shenzhen, Shenzhen 518057, China
| | - Y Chen
- Department of Hemodialysis, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - R L He
- Department of Anesthesia, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - K Qiao
- Department of Cardiothoracic Surgery, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - Y Wang
- Department of Anesthesia, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - Y X Liu
- Administration Office, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| | - Z Q Wang
- Administration Office, Shenzhen Third People's Hospitle, Shenzhen 518112, China
| |
Collapse
|
203
|
Tang Y, Xing Y, Cui L, Wu C, Wen X, Song H, Wu L, Chang H, Song J, Wang Y, Zhao G. Neurology practice during the COVID-19 outbreak and post-pandemic era: experiences and challenges. Eur J Neurol 2020; 27:e81-e83. [PMID: 32779848 PMCID: PMC7404871 DOI: 10.1111/ene.14445] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Accepted: 07/12/2020] [Indexed: 01/09/2023]
Affiliation(s)
- Y Tang
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - Y Xing
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - L Cui
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - C Wu
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - X Wen
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - H Song
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - L Wu
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - H Chang
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - J Song
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - Y Wang
- Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China
| | - G Zhao
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| |
Collapse
|
204
|
Liao HR, Wang S, Hu YL, Ding KH, Ye SY, Hu YW, Guo JC, Wu L. [Ergonomic risk factors of carpal tunnel syndrome in workers of an automobile factory]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2020; 38:196-199. [PMID: 32306692 DOI: 10.3760/cma.j.cn121094-20190420-00178] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the occurrence of pain symptoms and risk factors of carpal tunnel syndrome (CTS) in automobile manufacturing workers and provide theoretical basis for the prevention of CTS. Methods: From Nov.5th to Nov.19th, 2017, 446 workers in an automobile factory whose work age was above one year participate in questionnaires by cluster sampling. Chi square test and multifactor logistics regression analysis were used to analyze the factors related to the occurrence of CTS pain symptoms in workers. Results: The incidence of CTS pain among workers in this automobile factory was 20.8%. Working in the same position for a long time (OR=2.137, 95% CI:1.183-3.862) and unable to work reasonably because of uncomfortable posture (OR =2.067, 95% CI: 1.075-3.974) were identified as the risk factors of CTS pain symptoms by multifactor logistics regression analysis. Working age (OR=0.537, 95%CI:0.311-0.926) and work break (OR= 0.489, 95% CI: 0.282-0.849) were identified as the benefit factors of CTS pain symptoms. Conclusion: The incidence of CTS pain in automobile manufacturing workers is related to the posture in the process of labor . Effective ergonomic interventions should be carried out to prevent the occurrence of CTS pain in automobile manufacturing workers.
Collapse
Affiliation(s)
- H R Liao
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - S Wang
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - Y L Hu
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - K H Ding
- Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Clinical Medicine Department, Wuhan 430065, China
| | - S Y Ye
- Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Clinical Medicine Department, Wuhan 430065, China
| | - Y W Hu
- International School of Wuhan University of Science and Technology, Wuhan 430065, China
| | - J C Guo
- International School of Wuhan University of Science and Technology, Wuhan 430065, China
| | - L Wu
- Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Clinical Medicine Department, Wuhan 430065, China
| |
Collapse
|
205
|
Zhao X, Zhao L, Wu L, Zhang Y, Huang GY. [Efficacy of percutaneous transluminal renal angioplasty for pediatric renovascular hypertension: a meta-analysis]. Zhonghua Er Ke Za Zhi 2020; 58:661-667. [PMID: 32842387 DOI: 10.3760/cma.j.cn112140-20200424-00427] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the efficacy and the related factors of percutaneous transluminal renal angioplasty (PTRA) for pediatric renovascular hypertension (RVH) by a systematic review and meta-analysis. Methods: A systematic search was performed on international and domestic databases (Pubmed, Excerpt Medical Database (EMBASE), Cochrane library, Clinical trial.gov, Medline, China Biology Medicine (CBM), China national knowledge infrastructure (CNKI), VIP database and Wanfang) which included studies on PTRA for pediatric RVH from the establishment of the databases to March 2019. Key words of "pediatric" "children" "renal artery stenosis" "renovascular hypertension" "angioplasty" and "intervention" were used. Meta-analysis was made on the rate of technical success, clinical blood pressure improvement, complication and restenosis of PTRA as well as the predictors of its efficacy. The data consolidation, analysis of heterogeneity and sensitivity, and publication bias were performed using Comprehensive meta analyst and Open meta analyst software. Results: Seventeen observational non-controlled studies comprising 384 patients with RVH who underwent PTRA were identified. The technical success rate of PTRA was 93.9% (95% confidence interval (CI) 89.3%-97.5%). The improvement rate of blood pressure was 68.4% (95%CI 57.2%-78.7%), and the cure rate was 40.0% (95%CI 25.0%-55.8%). The subsequent subgroup analysis showed that there was no significant difference in the improvement rate of blood pressure after PTRA among the patients with RVH caused by fibromuscular dysplasia, Takayasu arteritis and neurofibromatosis type 1, respectively (P>0.05). The improvement rate of blood pressure in patients with combined lesions in renal artery branches was significantly lower than that in patients with lesions only in main renal artery (RR=1.659, 95%CI 1.023-2.689, P=0.040). It was found that 25.5% (95% CI 19.3%-32.2%) of patients required repeat procedure because of restenosis of lesions. Procedural complication of PTRA occurred in 8.3% (95%CI 3.5%-14.4%) of patients. In terms of clinical blood pressure improvement rate after PTRA, there was heterogeneity among the enrolled studies, but the results of meta-analysis were robust with low risk of publication bias (t=1.690, 95%CI -0.363-3.124, P=0.110). Conclusion: The result of the Meta-analysis suggests that PTRA may provide a safe and effective treatment for pediatric RVH, and patients with stenosis of renal arterial branches are associated with relatively poor clinical outcomes.
Collapse
Affiliation(s)
- X Zhao
- Cardiovascular Center, Children's Hospital of Fudan University, Shanghai 201102, China
| | - L Zhao
- Cardiovascular Center, Children's Hospital of Fudan University, Shanghai 201102, China
| | - L Wu
- Cardiovascular Center, Children's Hospital of Fudan University, Shanghai 201102, China
| | - Y Zhang
- Department of Clinical Epidemiology, Children's Hospital of Fudan University, Shanghai 201102, China
| | - G Y Huang
- Cardiovascular Center, Children's Hospital of Fudan University, Shanghai 201102, China
| |
Collapse
|
206
|
Xu L, Wu Z, He Y, Chen Z, Xu K, Yu W, Fang W, Ma C, Moqbel SAA, Ran J, Xiong Y, Wu L. MFN2 contributes to metabolic disorders and inflammation in the aging of rat chondrocytes and osteoarthritis. Osteoarthritis Cartilage 2020; 28:1079-1091. [PMID: 32416221 DOI: 10.1016/j.joca.2019.11.011] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/12/2019] [Revised: 11/04/2019] [Accepted: 11/05/2019] [Indexed: 02/02/2023]
Abstract
OBJECTIVE Metabolic disorders and inflammation of chondrocytes are major pathological changes in aging cells and osteoarthritis (OA). Recent studies demonstrated age-related mitochondrial dysfunction may be a key contributing factor in the development of OA. Mitofusin 2 (MFN2) is a key regulator of mitochondrial fusion, cell metabolism, autophagy and apoptosis. This study was performed to ascertain whether MFN2 was involved in the aging of chondrocytes and OA. METHODS Metabolic measurements were taken in rat chondrocytes between different ages (3-week, 5-month, 12-month). MFN2 activity was detected in both human and rat chondrocytes during aging and OA. Then, knockdown of MFN2 with small interfering RNA (siRNA) was performed to confirm whether MFN2 contributes to metabolic changes. Lentiviruses were used to establish MFN2-overexpression/knockdown OA models both in vivo and in vitro to confirm whether MFN2 contributes to OA progress. Further, regulatory mechanism of MFN2 was assessed and interaction between MFN2 and PARKIN was performed. RESULTS A metabolic shift to mitochondrial respiration was confirmed in rat chondrocytes during aging. MFN2 expression was elevated in both human and rat chondrocytes during aging and OA. Knockdown of MFN2 with siRNA reversed the age-related metabolic changes in rat chondrocytes. Overexpression of MFN2 exacerbated inflammation and OA progress, while knockdown of MFN2 ameliorated inflammation and OA progress. Further, MFN2 could be ubiquitinated by PARKIN, declined PARKIN expression during aging and OA might result in elevated MFN2 expression. CONCLUSIONS Elevated MFN2 contributes to metabolic changes and inflammation during aging of rat chondrocytes and osteoarthritis.
Collapse
Affiliation(s)
- L Xu
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Z Wu
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Y He
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Z Chen
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - K Xu
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - W Yu
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - W Fang
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - C Ma
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - S A A Moqbel
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - J Ran
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
| | - Y Xiong
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
| | - L Wu
- Department of Orthopedics Surgery, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
| |
Collapse
|
207
|
Zhang JZ, Qu LY, Wu L, Yi XN, Wang KY, Shao W, Huang SY. [Effect and underling mechanism of 6% hydroxyethyl starch 130/0.4 on serum albumen in trauma orthopedic patients during operation]. Zhonghua Yi Xue Za Zhi 2020; 100:2138-2143. [PMID: 32689756 DOI: 10.3760/cma.j.cn112137-20191114-02475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the effect of 6% hydroxyethyl starch 130/0.4(HES) on protein in severe trauma orthopedic patients after acute hemodilution. Methods: Fourty-eight severe trauma patients who met the inclusion criteria were selected from June 2018 to December 2018 in Yantaishan Hospital, and were randomly divided into two groups (n=24): group A and group B. Group A was ringer's sodium lactate control group, and group B was HES treatment group. After the tracheal intubation, the patients of group A were infused with 10% blood volume of sodium lactate ringer at 0.5 ml·kg(-1)·min(-1), and the patients in group B were infused with 10% blood volume of HES at 0.5 ml·kg(-1)·min(-1). Total protein (TP), human serum albumin (HSA), numbers of circulating endothelium cells (CEC), C-reactive protein (CRP), and serum levels of tumor necrosis factor-alpha (TNF-α), interleukin (IL)-10 and IL-6 were measured immediately after acute hemodilution (T(0)), 24 hours (T(1)) and 48 hours (T(2)) after acute hemodilution. After infusion into human body, HES bond to HSA, and fluorescence spectroscopy was used to analyze the binding relationship between HES and HSA in order to further study the effects of HES on HSA. Results: The HSA, TP, CEC, TNF-α, IL-6, IL-10, CRP at T(0) of group A were (38±5) g/L, (66±5) g/L, (5.5±0.4)/0.9 μl, (24±5) μg/L, (8.9±0.8) μg/L, (44±6) μg/L, (13.6±1.4) mg/L; While at T(1) were (33±5) g/L, (60±6) g/L, (10.2±0.7)/0.9 μl, (87±9) μg/L, (38.8±2.3) μg/L, (57±7) μg/L, (23.4±2.4) mg/L. The HSA, TP, CEC, TNF-α, IL-6, IL-10, CRP at T(0) of group B were(38±4)g/L, (66±5) g/L, (5.4±0.6)/0.9 μl, (24±6) μg/L, (9.1±0.9) μg/L, (45±6) μg/L, (13.4±1.8) mg/L; While at T(1) were (35±5)g/L, (62±5)g/L, (7.4±0.6)/0.9 μl, (70±8) μg/L, (29.5±3.1) μg/L, (72±6) μg/L, (19.7±2.2) mg/L. HSA and TP decreased at T(1) in group A as compared with T(0) (P<0.05), contrarily CEC increased significantly at T(1), TNF-ɑ, IL-6, IL-10 and CRP augmented at T(1) and T(2) in two groups (P<0.05). In comparison with the patients of group A, CEC decreased significantly at T(1) (P<0.05). TNF-ɑ, IL-6, CRP reduced significantly at T(1) and T(2) (P<0.05), but IL-10 increased at T(1) and T(2) in group B (P<0.05). The secondary structure of HSA changed after HES was added in the HES solution. The fluorescence intensity of HSA decreased with the increase of HES concentration,which suggested that HES induced HSA fluorescence quenching. HES could bind to Trp-214 residue in HSA at a molecular ration of 1∶1. Conclusions: 6% HES reduces the occurrence of low protein level in severe trauma patients after operation. HES could bind to Trp-214 amino acid residue in HSA and form the complex at a molecular ratio of 1∶1. The formation of HES-HSA complex increases the volume of HES, avoids the vascular leakage, protects the vascular endothelial cells, and induces anti-inflammatory immunity in the patients with capillary syndrome.
Collapse
Affiliation(s)
- J Z Zhang
- Department of Anesthesiology, Yantaishan Hospital, Yantai 264008, China
| | - L Y Qu
- Department of Anesthesiology, Yantaishan Hospital, Yantai 264008, China
| | - L Wu
- Department of Anesthesiology, Yantaishan Hospital, Yantai 264008, China
| | - X N Yi
- Department of Anesthesiology, Yantaishan Hospital, Yantai 264008, China
| | - K Y Wang
- Department of Anesthesiology, Yantaishan Hospital, Yantai 264008, China
| | - W Shao
- Department of Anesthesiology, Yantaishan Hospital, Yantai 264008, China
| | - S Y Huang
- Department of Oncology, Yantaishan Hospital, Yantai 264008, China
| |
Collapse
|
208
|
Wu L, Yu YH, Li L, Xu LY, Ruan XX, Lin CB, Zhao JP. [Clinical effect of nebulized acetylcysteine inhalation combined with bronchoscopy in the treatment of elderly patients with severe ventilator-associated pneumonia]. Zhonghua Shao Shang Za Zhi 2020; 36:267-272. [PMID: 32340416 DOI: 10.3760/cma.j.cn501120-20200229-00107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the clinical effect of nebulized acetylcysteine inhalation combined with bronchoscopy in treating elderly patients with severe ventilator-associated pneumonia (VAP). Methods: From January 2016 to December 2017, 80 elderly patients with severe VAP who were hospitalized in Zhejiang Hospital were divided into acetylcysteine+ bronchoscopy group [24 males and 16 females, aged (78±7) years] and bronchoscopy group [26 males and 14 females, aged (80±7) years]using random number table for a prospective cohort study. Patients in bronchoscopy group were treated with bronchoscopy in addition to conventional supportive care of symptoms. Patients in acetylcysteine+ bronchoscopy group received nebulized acetylcysteine inhalation therapy on the basis of the treatment given to patients in bronchoscopy group. Patients in both groups received treatment continuously for 7 days. The simplified clinical pulmonary infection score (CPIS) in both groups was assessed before and after treatment. Venous blood of 10 mL was collected before and after treatment to detect leukocyte count, serum C-reactive protein, and procalcitonin. Arterial blood of 1 mL was collected before and after treatment to detect partial arterial oxygen pressure (PaO(2)), partial arterial carbon dioxide pressure (PaCO(2)), oxygenation index. The inhalation platform pressure (Pplat), dynamic lung compliance (Cdyn), airway resistance, work of breathing, time of antibiotic use, and time of mechanical ventilation of patients in two groups were recorded before and after treatment. Data were statistically analyzed with chi-square test and t test. Results: (1) The simplified CPIS, leukocyte count, serum C-reactive protein, and procalcitonin of patients in acetylcysteine+ bronchoscopy group were significantly lower than those in bronchoscopy group after treatment (t=2.32, 2.15, 6.08, 7.12, P<0.05 or P<0.01). The simplified CPIS, leukocyte count, serum C-reactive protein, and procalcitonin of patients in acetylcysteine+ bronchoscopy group and bronchoscopy group after treatment were significantly lower than those before treatment (t=13.76, 13.60, 12.70, 8.32, 11.44, 14.28, 9.48, 9.50, P<0.01). (2) Compared with bronchoscopy group, patients in acetylcysteine+ bronchoscopy group had significantly higher PaO(2) and oxygenation index (t=4.14, 2.55, P<0.05 or P<0.01) but significantly lower PaCO(2) (t=4.36, P<0.01) after treatment. The PaO(2) and oxygenation index of patients in acetylcysteine+ bronchoscopy group after treatment were significantly higher than those before treatment (t=10.90, 43.72, P<0.01). The PaO(2) and oxygenation index of patients in bronchoscopy group after treatment were also significantly higher than those before treatment (t=6.55, 43.03, P<0.01). The PaCO(2) of patients in both groups after treatment were significantly lower than those before treatment (t=21.54, 21.92, P<0.01). (3) The Cdyn of patients in acetylcysteine+ bronchoscopy group after treatment was significantly higher than that in bronchoscopy group (t=5.41, P<0.01), and Pplat, airway resistance, and work of breathing were significantly lower than those in bronchoscopy group (t=2.18, 5.46, 2.49, P<0.05 or P<0.01). The Cdyn of patients in both groups after treatment were significantly higher than those before treatment (t=16.10, 10.90, P<0.01), and Pplat, airway resistance, and work of breathing were significantly lower than those before treatment (t=21.18, 11.13, 9.32, 15.50, 5.17, 5.97, P<0.01). (4)The time of mechanical ventilation and antibiotic usage of patients in acetylcysteine+ bronchoscopy group were (6.9±1.9)and (8.7±2.8) d, respectively, which were significantly shorter than (10.1±2.2) and (11.6±3.5) d in bronchoscopy group (t=6.85, 4.09, P<0.01). Conclusions: Nebulized acetylcysteine inhalation combined with bronchoscopy can significantly control the degree of lung infection in elderly patients with severe VAP, improve patients' respiratory mechanics parameter and blood gas analysis indicator, and shorten the time for mechanical ventilation and antibiotic usage.
Collapse
Affiliation(s)
- L Wu
- Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou 310013, China
| | - Y H Yu
- Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou 310013, China
| | - L Li
- Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou 310013, China
| | - L Y Xu
- Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou 310013, China
| | - X X Ruan
- Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou 310013, China
| | - C B Lin
- Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou 310013, China
| | - J P Zhao
- Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou 310013, China
| |
Collapse
|
209
|
Wei F, Shuai XX, Chen ZJ, Cao GL, Wang L, Qiu T, Hu T, Wu L, Zhang Q, Huang HX, Zhang YW, Zhu L, Cheng X. [Analysis on the efficacy and safety of fibrinolytic therapy in patients with acute ST-segment elevation myocardial infarction during the COVID-19 epidemic]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:472-476. [PMID: 32842256 DOI: 10.3760/cma.j.cn112148-20200331-00268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Objective: To evaluate the efficacy and safety of fibrinolysis strategy in patients with acute ST-segment elevation myocardial infarction (STEMI) during the COVID-19 epidemic, and to provide reference value for optimization of fibrinolytic process on the premise of prevention and control of COVID-19 transmission, including self-protection of medical staff. Methods: The efficacy and safety of fibrinolysis were retrospectively analyzed in 7 patients with acute STEM, who hospitalized from February 29, 2020 to April 3, 2020 in the Department of Cardiology, Wuhan Union Hospital of Tongji Medical College, Huazhong University of Science and Technology. To optimize the fibrinolytic process on the premise of prevention and control of COVID-19 transmission, including self-protection of medical staff, a full-time medical team in charge of fibrinolysis under third-grade protection was established. The acute STEMI patients were treated immediately in a fixed and isolated area in emergency department before receiving green channel fibrinolysis. Blood samples for complete blood count, COVID-19 antibody test and nasopharyngeal swab samples for COVID-19 nucleic acid test were made before fibrinolysis, while the chest CT examination was accomplished after fibrinolysis. By comparing differences of time from the first electrocardiogram (ECG) to fibrinolysis before and after the improvement of fibrinolytic process, the effect of optimization of the fibrinolytic process was evaluated. Results: In the present study, seven patients with acute STEMI received fibrinolysis therapy, 6 of them achieved reperfusion and no bleeding was observed in all of the patients. Five out of the 7 patients were hospitalized after fibrinolysis, and the hospitalization days were 19.6 days on average. By following up to April 14, 2020, none of the 7 patients died. The first 2 patients were treated according to the routine medical procedure and the time from the first ECG to fibrinolysis were 201 and 106 minutes, respectively. After the optimization of the fibrinolytic process, the time from the first ECG to fibrinolysis of the last 5 patients were 42, 46, 51, 43 and 54 minutes, respectively,which was significantly shorter than that before optimization. Conclusions: During the COVID-19 epidemic, fibrinolysis in patients with acute STEMI is safe, effective and easy to implement. Therefore, it is recommended as the top priority for the patients with acute STEMI with indications for fibrinolysis. On the premise of prevention and control of COVID-19 transmission, including self-protection of medical staff, the duration of myocardial ischemia can be shortened by optimization of the fibrinolytic process.
Collapse
Affiliation(s)
- F Wei
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - X X Shuai
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - Z J Chen
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - G L Cao
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - L Wang
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - T Qiu
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - T Hu
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - L Wu
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - Q Zhang
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - H X Huang
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - Y W Zhang
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - L Zhu
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| | - X Cheng
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022,China
| |
Collapse
|
210
|
Wu X, Wu L, Luo CN, Shi YM. AB1136 THE DIAGNOSTIC VALUE OF SERUM KL-6 IN CONNECTIVE TISSUE DISEASE ASSOCIATED INTERSTITIAL LUNG DISEASE IN THE UYGUR POPULATION OF CHINA. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.4860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Connective tissue diseases are a group of inflammatory, immune mediated disorders.Interstitial lung disease (ILD) is associated with significant morbidity and mortality.Currently,, scientists are still looking for serum markers to diagnose interstitial lung disease.Althought serum KL-6 level has been studied in ILD of various aetiologies and revealed to be an important serum marker for ILD,but differences in KL-6 expression related to ethnic and/or genetic variants may exist.Objectives:To evaluate the diagnosis of the serum Krebs von den Lungen-6 (KL-6) for CTD-ILD in the Uygur population of China.Methods:117 Patients with CTD-ILD (CTD-ILD group) and 182 patients with CTD (CTD group) who visited the department of rheumatology and immunology of People’s Hospital of Xinjiang Uygur Autonomous Region between January, 2015 and December, 2019 were included. Serum KL-6 levels were measured by chemiluminescent enzyme immunoassay kit.Results:The significantly higher levels of KL-6 were determined in the RA-ILD group than RA group [569(287.5,984)U/ml vs 194(152,266.5)U/ml](P<0.001)(figure 1).The optimal cutoff value of serum KL-6 for diagnosis of RA-ILD was 345.5 U/ml, and the sensitivity and specificity were71.8% and 90.1 %, respectively. Area Under the Curve (AUC) was 0.875.(figure 2)Figure 1.Comparison of serum KL-6 concentrations in CTD-ILD group and CTD group.Fig 2.Receiver-operating characteristic curve(ROC) of KL-6 for the diagnosis of CTD-ILDConclusion:The serum KL-6 is a important biomarker for the diagnosis of CTD-ILD and Serum KL-6 could be a clinically useful biomarker in screening CTD-ILD in the Uygur population of China.References:[1]Woodhead F, Wells A U, Desai S R. Pulmonary Complications of Connective Tissue Diseases[J]. Clinics in Chest Medicine, 2008, 29(29):149–164.Tanaka S, Hattori N, Ishikawa N, et al. Krebs von den Lungen-6 (KL-6) is a progn -ostic biomarker in patients with surgically resected nonsmall cell lung cancer. Int J Cancer 2012; 130:377–87.[2]Ogz E O, Kucuksahin O, Turgay M, et al. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study. Clinical Rheumatology, 2016, 35(3):663-666.Disclosure of Interests:None declared
Collapse
|
211
|
Dong L, LI S, Wu Z, Wang F, Zhang S, LI Q, Yu Y, Shen L, Luo L, Ji P, Liu W, Wang T, Xiao H, Jia S, Jia Y, Xiao F, Wu L. SAT0250 CLINICAL CHARACTERISTICS AND THE DISEASE ACTIVITY OF BEHCET’S DISEASE IN CHINA: A STUDY BASED ON SMART SYSTEM OF DISEASE MANAGEMENT (SSDM). Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.1470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Behcet´s disease (BD) is a systemic autoimmune disease that affects multiple organ systems with recurrent oral ulcers, genital ulcers and skin lesions. Behcet´s Disease Current Activity Form (BDCAF) and Electronic Medical Record-based Activity Index (EMRAI) are commonly used internationally to evaluate the disease activity of BD.Objectives:This study aimed to analyze the clinical characteristics, the level of disease activity, and the incidence of anxiety and depression for Chinese BD patients. Patients can perform self-management of disease with SSDM.Methods:SSDM is a series of doctor-patient interactive applications for self-management of patients with chronic diseases. Patients can perform self-assessment with SSDM and upload the data to their authorized doctors. The SSDM patients’ application system integrates the BDCAF and EMRAI into one scoring system. Patients could obtain scores of BDCAF and EMRAI by responding to one questionnaire through SSDM.Results:From Apr 2017 to Jan 2020, 719 BD patients from 166 hospitals used SSDM, with a mean age of 38.97±12.71 (14~81) years old, and median disease duration of 20.8 months. 719 patients performed BDCAF and EMRAI self-assessment 1321 times, 252 patients repeat assessments for 855 times. The mean score of BDCAF and EMRAI are 3.57±2.17 and 3.44±1.90, respectively. The matching degree of the two score was 0.8747.The most common clinical characteristics were oral ulcers (83.73%), ocular symptoms (62.03%), joint pain (50.07%). The comparative study between males and females revealed significant difference in the aspects of epididymitis (10.94% vs 0, p<0.001), genital ulcer (35.09% vs 44.93%, p=0.01), headache (24.15% vs 33.92%, p=0.01) and superficial thrombophlebitis (24.15% vs 33.92%, p=0.01). Table 1.Table 1.Clinical Characteristics of different systems in Chinese BD patients.Presence of clinical characteristicsTotalMalesFemalesP valueOral ulcer83.73% (602)86.42% (229)82.16% (373)0.14Genital ulcer41.31% (297)35.09% (93)44.93% (204)0.01*Epididymitis4.03% (29)10.94% (29)0 (0)<0.001**Erythema29.49% (212)29.43% (78)29.52% (134)0.98Skin lesions26.84% (193)28.68% (76)25.77% (117)0.4Superficial thrombophlebitis30.32% (218)24.15% (64)33.92% (154)0.01*Headache30.32% (218)24.15% (64)33.92% (154)0.01*Joint pain50.07% (360)51.32% (136)49.34% (224)0.61Arthritis14.60% (105)14.72% (39)14.54% (66)0.95Gastrointestinal involvement24.90% (179)27.92% (74)23.13% (105)0.15Ocular symptoms62.03% (446)62.64% (166)61.67% (180)0.79Nervous involvement23.78% (171)25.66% (68)22.69% (103)0.37Vascular involvement15.72% (113)18.11% (48)14.32% (65)0.18*P values are for the comparison between the males and females.Conclusion:Chinese BD patients can effectively perform BDCAF and EMRAI self-assessment with SSDM. The results of the assessment conducted by the two scoring systems are similar. The clinical characteristics of Chinese BD were different depending on gender.Acknowledgments: :Smart system of disease management (SSDM) was developed by Shanghai Gothic Internet Technology Co., Ltd.Disclosure of Interests:None declared
Collapse
|
212
|
Song H, Wei H, Zhang M, Wu L, Wu Z, Aichun C, Wang B, Wang X, Fan W, Chen X, Wu H, Zhou W, Xiao H, Du Z, Wu B, Jia Y, Xiao F, Lu J. FRI0593 CORRELATION BETWEEN DISEASE ACTIVITY AND MENTAL HEALTH OF AS PATIENTS: A CROSS-SECTION STUDY WITH SELF-ASSESSMENTS BASED ON SMART SYSTEM OF DISEASE MANAGEMENT (SSDM) MOBILE TOOLS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.1774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:WHO survey showed that the prevalence of anxiety and depression in Chinese population and Chinese patients with chronic diseases were between 3.1% - 4.2% and 3.1% - 7.3%, respectively. Ankylosing Spondylitis Disease Activity Score (ASDAS) and Hospital Anxiety and Depression Scale (HADS) are commonly used to evaluate AS patients’ disease activity and mental health. All those assessments were mainly performed by health professionals (HCPs) with paper questionnaire previously. SSDM is a novel smart disease management tool that allows patients to do self-assessments on ASDAS and HADS by mobile terminals.Objectives:To estimate the prevalence of anxiety and depression in Chinese patients with AS and to analyze the potential association between disease activity and mental health.Methods:Under the guidance and training by HCPs, AS patients downloaded SSDM and performed self-assessments bundle of ASDAS and HADS with SSDM. ASDAS<=1.3, 1.3-2.1, 2.1-3.5 and >3.5 are defined as inactive (IDA), moderate (MDA), high (HDA) and very high (VHDA) disease activity, respectively. ASDAS score <=1.3 represents inactive disease status and achievement of T2T. HADS score >=8 can be diagnosed with anxiety or depression.Results:From June 2016 to Jan 2020, 1,931 AS patients (1,118 male, 813 female) with a mean age of 34.09 ± 11.86 (12-82) years and the median disease duration of 2.61 years from 207 hospitals performed bundle self-assessments for 2,477 times in total. According to the HADS and ASDAS assessment results, the prevalence of anxiety and depression in all patients was 36.7% and 39.3% respectively, which was significantly higher than that in the WHO survey in Chinese population and chronic disease patients. The proportion of patients achieved and failed on T2T was 29% and 71%, respectively. The prevalence of anxiety (A) and depression (D) was 25% and 23% among T2T achievers; and 37% and 32% among T2T failures, respectively (pA<0.05, pD<0.05).According to ASDAS, in IDA, MDA, HDA and VHDA subgroups, the prevalence of anxiety and depression was 27%, 36%, 41%, 52% and 29%, 38%, 45%, 56%, respectively. The correlation coefficients of anxiety (A) and depression (D) with ASDAS were rA=0.9908 and rD=0.9964. It suggested that with the increase of disease activity, the proportion of AS patients with anxiety and depression increased significantly. (Figure 1)Figure 1.The prevalence of anxiety and depression according to ASDAS.Conclusion:The prevalence of anxiety and depression in AS patients was significantly higher than that in the WHO survey in Chinese population and chronic disease patients. Higher prevalence of anxiety and depression were associated with higher levels of disease activity. SSDM is an effective mobile interface to monitor and study entanglement of disease activity and mental health in AS patients, which build a foundation for proactive interventions in future.Acknowledgments:Smart system of disease management (SSDM) was developed by Shanghai Gothic Internet Technology Co., Ltd.Disclosure of Interests:None declared
Collapse
|
213
|
Maimaitiyakefu A, Wu L. AB0504 THE DIFFERENCES OF IMMUNE CHARACTERISTICS AND ITS RELATIONSHIP WITH DISEASE ACTIVITY IN LARGE VESSEL VASCULITIS PATIENTS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.4126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Large vessel vasculitis(LVV) is a rare refractory disease, giant cell arteritis (GCA) and Takayasu arteritis (TAK) constitute different types of primary LVV.Despite considerable discussion on the potential differences between GCA and TAK, the immunological difference and its relationship to disease activity remains unclear.Objectives:To investigate the differences of peripheral blood immuno-phenotype between TAK and GCA, and to analyze the correlation between immune metabolism level and disease activity in TAK.Methods:All patients with TAK and GCA who come to our department from January 2010 to January 2020 were included, all of them met the classification criteria of American college of rheumatology.General information, clinical manifestations, laboratory index, artery involvement and therapeutic schedule were collected.According to the National Institutes of Health criteria, there were 29 active and 23 inactive TAK patients.Results:[1]Baseline characteristics, treatment,involvement artery in LVV patients are summarized in Table 1.Table 1.Clinical characteristics of patients with LVVVariableTAK,n=52GCA,n=4Age,X±S29±1364±7Female,n(%)45(86.6)1(25)Constitutional symptoms,n(%)23 (43.4)3(75)Cephalic symptoms,n(%)33 (62.3)2 (50)Peripheral limb ischemia,n(%)22 (41.5)-Ocular signs,n(%)3 (5.7)2 (50)Stroke,n(%)2 (3.8)-GC,n(%)40(76.9)3(75)GC dose >7.5mg/day,n(%)36 (90)2 (66.7)Surgical intervention,n(%)7(13.2)-Coronary artery,n(%)3(5.7)-Common carotid artery,n(%)31(58.5)-Subclavian artery,n(%)23(43.4)-thoracic aorta,n(%)6(11.3)-abdominal aorta,n(%)13(24.5)-GC Glucocorticoids,bDMARDS biologic DMARDs(2)Compared with GCA patients,TAK patients were younger (29±13vs64±7,P=0.015), with higher peripheral blood lymphocyte count of CD8+T cells and lower CD4/CD8(Table 2).Table 2.Comparison of peripheral immune cells,humoral immunity among TAK and GCA,active and inactive TAKVariableTAK,n=52GCA,n=4p valueinactive TAK,n=23active TAK,n=29p valueNeutrophils5.5±2.35.8±1.10.8274.4±1.66.3±2.50.009*Lymphocytes2.4±0.81.0±0.60.010*2.3±0.72.4±0.90.901Monocytes0.5±0.20.7±0.10.2180.5±0.20.6±0.20.431CD3+T1959±4901154±5410.1892195±921842±5850.467CD4+T1074±305758±3030.3811250±198987±3330.376CD8+T859±212297±870.048*945±41815±2580.542CD4+CD8+42±2712±70.34463±232±280.229CD4-CD8-90±7591±630.99997±7487±680.914CD19+B273±97191±940.470202±106309±840.242CD16+CD56+135±72104±670.709112±63146±830.639CD4/CD81.25±0.152.55±0.510.001*1.33±0.261.21±0.100.440IgG11.7±3.78.3±0.50.12410.3±3.412.9±3.60.025*IgA2.6±1.32.3±0.80.7242.1±1.33.0±1.10.021*IgM1.7±0.90.8±0.20.1181.5±0.81.8±0.90.202Κ light chain9.5±3.96.6±0.30.2228.1±3.310.8±4.00.033*λ light chain5.2±1.93.9±0.30.2604.7±1.95.8±1.90.086*P<0.05(3)The levels of neutrophils, monocytes,IgG, IgA and Κ light chain active TAK were higer than inactive TAK, with lower lymphocyte level (Table 2). Further correlation analysis showed that the levels of neutrophils, IgG,IgA and Κ light chain were positively correlated with disease activity (r=0.434,P=0.005;r=0.380,P=0.019;r=0.452,P=0.004;r=0.380,P=0.022).Conclusion:Compared with GCA patients,TAK patients had higer level of CD8+T lymphocytes, consistenting with previous studies.In addition,TAK patients had persistent immune cell involvement,while humoral immunity is related to disease activity.Deeper studies may be required about the role of immune profile in in large vessel vasculitis.References:[1]Miyabe C, Miyabe Y, et al. An expanded population of pathogenic regulatory T-cells in giant cell arteritis is abrogated by IL-6 blockade therapy. Ann Rheum Dis. 2017;76:898–905.[2]Kermani TA, Crowson CS, Muratore F, Schmidt J, Matteson EL, Warrington KJ. Extra-cranial giant cell arteritis and Takayasu arteritis: how similar are they? Semin Arthritis Rheum. 2015;44:724–8.Disclosure of Interests:None declared
Collapse
|
214
|
Chen X, Wu L, Wu X, Luo CN, Shi YM. FRI0435 THE CLINICAL SIGNIFICANCE OF SERUM AUTOANTIBODIES AND HLA-B27 MOLECULE TESTING IN UYGUR PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.5155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:AIDS is a deadly infectious disease caused by the HIV. When HIV infects a host, it may induce production of autoantibodies due to the structural antigen similarity between viral proteins and selfantigens.The molecular mimicry between HIV protein and self-antigens could cause antibody cross-reactions and lead to development of autoimmune disease.Objectives:To explore the clinical value of serum autoantibodies and human leukocyte antigen (HLA-B27) molecular testing in Uygur patients with human immunodeficiency virus (HIV) infection.Methods:A total of 727 HIV-infected Uygur patients who visited Kuche Infectious Diseases Hospital during May 2016 to March 2017 were include in this study. The other 390 healthy people were enrolled as controls. Serum antinuclear antibodies (ANA) and ANA Profile, anti-cyclic citrullinated peptide (CCP) antibody, and HLA-B27 molecule were tested.Results:Among 727 HIV-infected Uygur patients, 317 were males and 410 were females with mean age (35.52±13.44) years old. The mean duration of disease was (6.34±3.05)years. There were 697(95.87%) patients receiving Highly active antiretroviral therapy (HAART) with mean duration of treatment (6.34±3.05)years. Rheumatic manifestations were recorded in 238 (32.74%) HIV-infected Uygur patients, mainly with dry mouth and dry eye (15.41%), alopecia (9.90%), arthralgia (8.94%), ect. Compared with the health controls, positive ANA was more common in HIV infected Uygur patients (33.42%vs.17.43%,P< 0.001) with low titers (ANA titer:1:100). HIV-infected Uygur patients had higher positive anti-u1-RNP antibodies positive rate (1.10%), but lower anti-SSA antibodies positive rate (0.14%) and anti-CCP antibodies positive rate (0.28%). Patients with positive ANA in HAART group were significantly less than that in non-treatment group (38.72%vs.50.00%,P=0.049).Only one female patient was HLA-B27 positive (0.14%), which was significantly lower than that in healthy controls (3.08%) (P<0.001). Also, only one patient was diagnosed with rheumatoid arthritis (RA).Conclusion:Rheumatic manifestations are common in HIV-infected Uygur patients. Several autoantibodies are positive, but the coincidence of rheumatic diseases is rare. It’s noted that patients with Rheumatic manifestations and low titre positive ANA should be considered as a differential diagnosis of HIV infection.Disclosure of Interests:None declared
Collapse
|
215
|
Shi YM, Wu X, Wu L, Luo CN. AB0446 CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF 484 SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN XINJIANG OF CHINA: A COMPARATIVE ANALYSIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.4871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease. Epidemiological studies in SLE have been reported in the literature in many countries and ethnic groups. Although SLE in China has been described in the past, there has not been a detailed evaluation of SLE patients in Xinjiang of China, a largely Uygur population.Objectives:To describe the clinical featuresand immunological features of 484 SLE subjects.Methods:484 adult patients followed in the The People’s Hospital of the Xinjiang Uygur Autonomous Region, 211 patients with Uygur SLE as welI as 273patients with Han SLE.Results:Of the 211 Uygur SLE patients, 195 (92.4%) were female and 16 (7.6%) were male (female:male=12.2:1),the mean age at SLE onset was 34.67±11.57 years, mean disease duration was 20.77±35.16 months.Of the 273 Han SLE patients,247(90.5%)were female and 26(9.5%) were male,the mean age at SLE onset was 36.68±14.44 years,mean disease duration was 41.64±61.89 months.(2)between the Uygur and Han SLE patients,the Raynaud phenomenon(χ2=6.066 P=0.014), Chest pain(χ2=7.906 P=0.005), headache(χ2=4.572 P=0.029)has obvious differences(table 1).(3)The anti-nuclear (χ2=8.108 P=0.004), anti-AHA (χ2=4.952 P=0.026)were higer in Uygur SLE patients than those in Han SLE patients;the Uygur SLE patients has been anemia(χ2=6.904,P=0.009), high level of immunoglobulin (χ2=8.939,P=0.003),decrease of complement(χ2=6.330 P=0.012).(table 2)figure 1. Clinical manifestationsClinical manifestationsUygur SLE patients(n=211)Han SLE (n=273)χ2Prash106(50.2%)157(57.5%)2.5370.111Photosensitivity40(19%)56(20.5%)0.1810.670Alopecia73(34.6%)101(37.0%)0.2980.585Oral ulcers49(23.2%)64(23.5%)0.0060.937Raynaud phenomenon28(13.3%)60(22%)6.0660.014livedo reticularis5(2.4%)7(2.6%)0.0200.866arthralgia/arthritis105(49.8%)159(58.5%)3.6230.057abnormal liver-function8(3.8%)7(2.6%)0.5970.440Chest pain28(13.3%)16(5.9%)7.9060.005Suffocation49(23.2%)52(19%)1.2560.262palpitation27(12.8%)41(15%)0.4870.485Shortness of breath24(11.4%)35(12.8%)0.2330.630Ophthalmia2(0.9%)6(2.2%)1.1540.283Visual impairment1(0.5%)3(1.1%)0.5670.457hemiplegia1(0.5%)0(0.0%)1.2970.436Mental disorder4(1.9%)11(4.0%)1.8040.179headache14(6.6%)7(2.6%)4.5720.029Lower Limb Edem36(17.1%)34(12.5%)2.0420.153pleurisy37(17.5%)43(15.8%)0.2560.613pericarditis38(18%)33(12.1%)3.2730.070pulmonary fibrosis7(3.3%)9(3.3%)0.0000.982figure 2. immunological manifestationsmanifestationsUygur SLE patients(n=211)Han SLE (n=273)χ2Pantinuclear antibodies185(87.7%)212(77.7%)8.1080.004anti-dsDNA115(54.5%)144(52.7%)0.1470.701anti-SSA101(47.9%)149(54.6%)2.1470.143anti-SSB45(21.3%)63(23.1%)0.2100.647anti-Sm44(21%)68(25%)1.0880.297ACL29(13.8%)26(9.5%)2.1610.142antiU1-RNP74(35.1%)100(36.6%)0.1260.723anti-AHA60(28.4%)54(19.8%)4.9520.026Low white blood cell46(22.1%)79(29%)2.9380.087anemia90(42.9%)85(36.3%)6.9040.009Thrombocytopenia36(17.1%)51(18.7%)0.2120.645Urine protein positive84(39.8%)114(41.9%)0.2170.641Rise of urine RBC29(13.7%)35(12.8%)0.0880.766Increased immunoglobulin82(38.9%)71(26.1%)8.9390.003Complement decline120(57.1%)124(45.6%)6.3300.012Conclusion:The Uygur SLE patients have their own clinical and immunological characteristics, which has guiding significance in the diagnosis, treatment and prognosis of SLE.References:[1]Martyna TS,Hanna SS, Marek F. Clinical and immunological characteristics of Polish patients with systemic lupus erythematosus. Adv Clin Exp Med. 2018;27(1):57–61[2]Maloney K C, Ferguson T S, Stewart H D, et al. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: A comparative analysis[J]. Lupus, 2017, 26(13):961203317707828.[3]Ching K H, Burbelo P D, Christopher T, et al. Two Major Autoantibody Clusters in Systemic Lupus Erythematosus[J]. PLoS ONE, 2012, 7(2):e32001.Disclosure of Interests:None declared
Collapse
|
216
|
Chen G, Wu L. FRI0571 THE DIAGNOSTIC VALUE OF KL-6 IN RHEUMATOID ARTHRITIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE IN XINJIANG OF CHINA. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.5736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Rheumatoid arthritis (RA) is a systemic inflammatory disease.Many researchers have observed that extra articular organs were highly involved in RA patients.The most common extra-articular manifestations were pulmonary involvement.Serum levels of KL-6 have been reported to be elevated in various ILD such as idiopathic pulmonary fibrosis, collagen vascular disease associated interstitial pneumonias, and other interstitial lung disorders.However, little is known regarding the usefulness of this biomarker in connective tissue diseases related interstitial lung diseases(CTD-ILD). Especially,the diagnostic value of KL-6 in interstitial lung disease associated with rheumatoid arthritis(RA-ILD) still has a dispute.Objectives:To assess the diagnosis of the serum Krebs von den Lungen-6(KL-6) for RA-ILD patients in Xinjiang of China.Methods:This retrospective study included 184 patients with RA in who visited the department of rheumatology and immunology of People’s Hospital of Xinjiang Uygur Autonomous Region between January, 2015 and December, 2019.The patients were divided into RA-ILD group(n=95) and RA group(n=89) according to the presence of ILD. Serum KL-6 concentration (U/mL) was measured using the chemiluminescent enzyme immunoassay kit.Results:The mean age(p < 0.001) and median value of CCP (p = 0.006) were significantly higher in the RA-ILD group.RA-ILD group had elevated serum KL-6 levels compared to RA group [447(281, 687)U/ml vs 195(151.5,265.5)U/ml](p < 0.001)(figure 1).According to the Receiver Operating Characteristic Curve (ROC) analysis, the area under the curve was of 0.879 and the optimal cut-off value of serum KL-6 to discriminate the presence of ILD was 277 U/ml, with sensitivity of 77.9%, specificity of 79.8%(figure 2).Figure 1.Comparison of serum KL-6 concentrations in RA-ILD group and RA group.Figure 2.Receiver-operating characteristic curve(ROC) of KL-6 for the diagnosis of RA-ILDConclusion:The present study confirms that KL-6 is a biological marker which is associated with RA-ILD. Furthermore, Patients with RA who are older and have a higher value of CCP are more likely to develop ILD.References:[1] Anaya JM, Diethelm L, Ortiz LA et al (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24:242–254[2] Bonella F, Costabel U (2014) Biomarkers in connective tissue disease-associated interstitial lung disease. Semin Respir Crit Care Med 35:181–200[3] Doishita S, Inokuma S, Asashima H et al (2011) Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseases. Intern Med 50: 2889–2892Disclosure of Interests:None declared
Collapse
|
217
|
Meng H, Mo Y, Cheng T, Zhang H, Wu L, Shah NK, Shu C, He J. Spontaneous rupture of kidney during pregnancy. J BIOL REG HOMEOS AG 2020; 34:643-646. [PMID: 32460466 DOI: 10.23812/20-84-l-34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- H Meng
- Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin China
| | - Y Mo
- Department of Obstetrics and Gynecology, The Norman Bethune Medical Institute of Jilin University, Changchun, Jilin China
| | - T Cheng
- Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin China
| | - H Zhang
- Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin China
| | - L Wu
- Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin China
| | - N K Shah
- Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin China
| | - C Shu
- Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin China
| | - J He
- Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Jilin University, Changchun, Jilin China
| |
Collapse
|
218
|
Lv W, Linpeng S, Li Z, Liang D, Jia Z, Meng D, Cram DS, Zhu H, Teng Y, Yin A, Wu L. Noninvasive prenatal diagnosis for pregnancies at risk for β-thalassaemia: a retrospective study. BJOG 2020; 128:448-457. [PMID: 32363759 DOI: 10.1111/1471-0528.16295] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/16/2020] [Indexed: 01/08/2023]
Abstract
OBJECTIVE To evaluate the clinical feasibility of noninvasive prenatal diagnosis (NIPD) for β-thalassaemia using circulating single molecule amplification and re-sequencing technology (cSMART). DESIGN Through carrier screening, 102 pregnant Chinese couples carrying pathogenic HBB gene variants were recruited to the study. Pregnancies were managed using traditional invasive prenatal diagnosis (IPD). Retrospectively, we evaluated the archived pregnancy plasma DNA by NIPD to evaluate the performance of our cSMART assay for fetal genotyping. SETTING Chinese prenatal diagnostic centres specialising in thalassaemia testing. POPULATION Chinese carrier couples at high genetic risk for β-thalassaemia. METHODS Fetal cell sampling was performed by amniocentesis and HBB genotypes were determined by reverse dot blot. NIPD was performed by a newly designed HBB cSMART assay and fetal genotypes were called by measuring the allelic ratios in the maternal cell-free DNA. MAIN OUTCOME MEASURES Concordance of HBB fetal genotyping between IPD and NIPD and the sensitivity and specificity of NIPD. RESULTS Invasive prenatal diagnosis identified 29 affected homozygotes or compound heterozygotes, 54 heterozygotes and 19 normal homozygotes. Compared with IPD results, 99 of 102 fetuses (97%) were correctly genotyped by our NIPD assay. Two of three discordant samples were false positives and the other sample involved an incorrect call of a heterozygote carrier as a homozygote normal. Overall, the sensitivity and specificity of our NIPD assay was 100% (95% CI 88.06-100.00%) and 97.26% (95% CI 90.45-99.67%), respectively. CONCLUSIONS This study demonstrates that our cSMART-based NIPD assay for β-thalassaemia has potential clinical utility as an alternative to IPD for pregnant HBB carrier couples. TWEETABLE ABSTRACT A new noninvasive test for pregnancies at risk for β-thalassaemia.
Collapse
Affiliation(s)
- W Lv
- Centre for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.,Hunan Jiahui Genetics Hospital, Changsha, Hunan, China
| | - S Linpeng
- Centre for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China
| | - Z Li
- Centre for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China
| | - D Liang
- Centre for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.,Hunan Jiahui Genetics Hospital, Changsha, Hunan, China
| | - Z Jia
- Prenatal Diagnosis Centre of Hunan Province, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China
| | - D Meng
- Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, China
| | - D S Cram
- Berry Genomics Corporation, Beijing, China
| | - H Zhu
- Centre for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China
| | - Y Teng
- Hunan Jiahui Genetics Hospital, Changsha, Hunan, China
| | - A Yin
- Prenatal Diagnosis Centre, Guangdong Women and Children Hospital, Guangzhou, Guangdong, China
| | - L Wu
- Centre for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China
| |
Collapse
|
219
|
Li Z, Liu Y, Li Y, Lin F, Wu L. Screening and identification of
Monascus
strains with high‐yield monacolin K and undetectable citrinin by integration of HPLC analysis and
pksCT
and
ctnA
genes amplification. J Appl Microbiol 2020; 129:1410-1418. [DOI: 10.1111/jam.14689] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2019] [Revised: 03/31/2020] [Accepted: 04/27/2020] [Indexed: 02/06/2023]
Affiliation(s)
- Z. Li
- Fujian Engineering and Research Center for Microbial Techniques of Hongqu Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian Province People’s Republic of China
| | - Y. Liu
- Fujian Engineering and Research Center for Microbial Techniques of Hongqu Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian Province People’s Republic of China
| | - Y. Li
- Fujian Xianzhilou Biological Science & Technology Co., LTD Fuzhou Fujian Province People’s Republic of China
| | - F. Lin
- Fujian Engineering and Research Center for Microbial Techniques of Hongqu Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian Province People’s Republic of China
| | - L. Wu
- Fujian Engineering and Research Center for Microbial Techniques of Hongqu Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian Province People’s Republic of China
| |
Collapse
|
220
|
Zhao N, Zhou ZL, Wu L, Zhang XD, Han SB, Bao HJ, Shu Y, Shu XG. An update on the status of COVID-19: a comprehensive review. Eur Rev Med Pharmacol Sci 2020; 24:4597-4606. [PMID: 32374000 DOI: 10.26355/eurrev_202004_21046] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).
Collapse
Affiliation(s)
- N Zhao
- Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
| | | | | | | | | | | | | | | |
Collapse
|
221
|
Fan DG, Wu CL, Huang HJ, Wu L, Chen H, Cai SS, Lin N, Lin SY. [Paraganglioma of urinary bladder: a clinicopathological features analysis of 23 cases]. Zhonghua Bing Li Xue Za Zhi 2020; 49:311-316. [PMID: 32268666 DOI: 10.3760/cma.j.cn112151-20190928-00535] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the clinicopathological features, diagnosis, differential diagnosis and immunohistochemical (IHC) characteristics of paraganglioma of urinary bladder (PUB). Methods: The clinical and pathological data of 23 cases of PUB were collected at the Second Affiliated Hospital of Fujian Medical University (7 cases); Fujian Provincial Hospital (8 cases); Fujian Medical University Union Hospital (6 cases); and First Affiliated Hospital of Fujian Medical University (2 cases) from May 2010 to November 2018. IHC staining for CK, GATA3, CD56, Syn, CgA, S-100 protein, HMB45, SDHB, OCT3/4 and Ki-67 was done using EliVision method; and the relevant literature was reviewed. Results: There were 14 women and 9 men, aged ranged from 21 to 73 years (median 51 years). Clinically, patients presented with headache, vertigo, palpitation, hypertensive crisis during micturition, hypertension, blurred vision, gross hematuria and paroxysmal pallor. The tumor sizes ranged from 0.9 to 6 cm (mean2.5 cm). Macroscopically, most tumors were exophytic and well delineated within the lamina propria or muscularis propria. The tumors were firm and nodular and showed grayish-tan cut surface. Histologically,the tumor growth pattern was expansive or showed interpenetrating infiltrative growth within the lamina propria or muscularis propria; the tumor cells were typically arranged in distinctive nests (Zellballen) with organoid arrangement; pseudo-rosette were seen in some cases. The cells were rounded or polygonal and had rich, acidophilic or amphophilic cytoplasm and may contain pigmented granules and vacuoles; the nuclei were central or eccentric, with small nucleoli, although occasionally some nuclei were pleomorphic and hyperchromatic. Spindled sustentacular cells could be seen around the nests of tumor cells in some cases. There were abundant vessels that were fissure-like, hemangioma-like or dilated. By IHC, the tumor cells were positive for GATA3 (2/23), OCT3/4 (2/23), CD56 (22/23), Syn (23/23), CgA (22/23), S-100 (sustentacular cell, 23/23) and SDHB (23/23); and negative for CK and HMB45; Ki-67 index was 1%-5%. At follow-up, there was no recurrence or metastasis in 18 cases. Conclusions: The diagnosis of PUB relies on the morphologic and IHC features; but there may be histomorphologic heterogeneity. The most important differential diagnosis is invasive urothelial carcinoma. The tumor cells may show aberrant cytoplasmic expression of OCT3/4; there is no clear correlation between SDHB and OCT3/4 expression in the group.
Collapse
Affiliation(s)
- D G Fan
- Department of Pathology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
| | - C L Wu
- Department of Pathology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
| | - H J Huang
- Department of Pathology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, China
| | - L Wu
- Department of Pathology, Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - H Chen
- Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350001, China
| | - S S Cai
- Department of Pathology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
| | - N Lin
- Department of Pathology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
| | - S Y Lin
- Department of Pathology, Fujian Provincial Hospital, Provincial Clinical Medical College of Fujian Medical University, Fuzhou 350001, China
| |
Collapse
|
222
|
Zhao Y, Wanggou S, Ding M, Dong X, Zhao G, Diao Y, Yao Y, Wu L, Granton J, de Perrot M. Single Cell RNA Sequencing of Human Pulmonary Endarterectomy Specimen Reveals Distinct Cell Populations and Gene Profiles. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.1181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
223
|
Wei QC, Ye SF, Wang YP, Ding SY, Qian NJ, Liu YH, Chen HB, Wu L, Pan XH. [Brugada syndrome with complete right bundle branch block successfully treated with low dose quinidine: a case report]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:154-156. [PMID: 32135617 DOI: 10.3760/cma.j.issn.0253-3758.2020.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Q C Wei
- Department of Cardiology, Second Affiliated Hospital, Medical Collage of Zhejiang University, Hangzhou 310009, China
| | - S F Ye
- Department of Cardiology, Second Affiliated Hospital, Medical Collage of Zhejiang University, Hangzhou 310009, China
| | - Y P Wang
- Department of Cardiology, Second Affiliated Hospital, Medical Collage of Zhejiang University, Hangzhou 310009, China
| | - S Y Ding
- Department of Cardiology, Second Affiliated Hospital, Medical Collage of Zhejiang University, Hangzhou 310009, China
| | - N J Qian
- Department of Cardiology, Second Affiliated Hospital, Medical Collage of Zhejiang University, Hangzhou 310009, China
| | - Y H Liu
- Department of Cardiology, Second Affiliated Hospital, Medical Collage of Zhejiang University, Hangzhou 310009, China
| | - H B Chen
- Department of Cardiology, Second Affiliated Hospital, Medical Collage of Zhejiang University, Hangzhou 310009, China
| | - L Wu
- Department of Cardiology, Peking University First Hospital, Beijing 100034, China
| | - X H Pan
- Department of Cardiology, Second Affiliated Hospital, Medical Collage of Zhejiang University, Hangzhou 310009, China
| |
Collapse
|
224
|
Luo JY, He PK, Yan GX, Wu L. [Differential diagnosis and managements of torsades de pointes and polymorphic ventricular tachycardia]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:168-172. [PMID: 32135621 DOI: 10.3760/cma.j.issn.0253-3758.2020.02.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- J Y Luo
- Department of Cardiology, Peking University First Hospital, Beijing 100034, China
| | - P K He
- Department of Cardiology, Peking University First Hospital, Beijing 100034, China
| | - G X Yan
- Lankenau Medical Center, Thomas Jefferson University, Philadelphia PA19096, USA
| | - L Wu
- Department of Cardiology, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
225
|
Lin G, Li C, Li PS, Fang WZ, Xu HP, Gong YH, Zhu ZF, Hu Y, Liang WH, Chu Q, Zhong WZ, Wu L, Wang HJ, Wang ZJ, Li ZM, Lin J, Guan YF, Xia XF, Yi X, Miao Q, Wu B, Jiang K, Zheng XB, Zhu WF, Zheng XL, Huang PS, Xiao WJ, Hu D, Zhang LF, Fan XR, Mok TSK, Huang C. Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma. Ann Oncol 2020; 31:517-524. [PMID: 32151507 DOI: 10.1016/j.annonc.2020.01.014] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2019] [Revised: 01/05/2020] [Accepted: 01/15/2020] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Adenosquamous carcinoma (ASC) of the lung is a heterogeneous disease that is composed of both adenocarcinoma components (ACC) and squamous cell carcinoma components (SCCC). Their genomic profile, genetic origin, and clinical management remain controversial. PATIENTS AND METHODS Resected ASC and metastatic tumor in regional lymph nodes (LNs) were collected. The ACC and SCCC were separated by microdissection of primary tumor. The 1021 cancer-related genes were evaluated by next-generation sequencing independently in ACC and SCCC and LNs. Shared and private alterations in the two components were investigated. In addition, genomic profiles of independent cohorts of adenocarcinomas and squamous cell carcinomas were examined for comparison. We have also carried out a retrospective study of ASCs with known EGFR mutation status from 11 hospitals in China for their clinical outcomes. RESULTS The most frequent alterations in 28 surgically resected ASCs include EGFR (79%), TP53 (68%), MAP3K1 (14%) mutations, EGFR amplifications (32%), and MDM2 amplifications (18%). Twenty-seven patients (96%) had shared variations between ACC and SCCC, and pure SCCC metastases were not found in metastatic LNs among these patients. Only one patient with geographically separated ACC and SCCC had no shared mutations. Inter-component heterogeneity was a common genetic event of ACC and SCCC. The genomic profile of ASC was similar to that of 170 adenocarcinomas, but different from that of 62 squamous cell carcinomas. The incidence of EGFR mutations in the retrospective analysis of 517 ASCs was 51.8%. Among the 129 EGFR-positive patients who received EGFR-TKIs, the objective response rate was 56.6% and the median progression-free survival was 10.1 months (95% confidence interval: 9.0-11.2). CONCLUSIONS The ACC and SCCC share a monoclonal origin, a majority with genetically inter-component heterogeneity. ASC may represent a subtype of adenocarcinoma with EGFR mutation being the most common genomic anomaly and sharing similar efficacy to EGFR TKI.
Collapse
Affiliation(s)
- G Lin
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - C Li
- Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China; Department of Pathology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China
| | - P S Li
- Geneplus-Beijing, Beijing, China
| | - W Z Fang
- Department of Oncology, 900 Hospital of the Joint Logistics Team, Clinical Medical College of Fujian Medical University in 900 Hospital of the Joint Logistics Team, Fuzhou, China
| | - H P Xu
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - Y H Gong
- Geneplus-Beijing, Beijing, China
| | - Z F Zhu
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Fudan University Shanghai Medical School, Shanghai, China
| | - Y Hu
- Department of Medical Oncology, Chinese PLA General Hospital/Medical School of Chinese PLA, Beijing, China
| | - W H Liang
- Department of Thoracic Oncology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China
| | - Q Chu
- Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - W Z Zhong
- Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
| | - L Wu
- Department of Thoracic Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China
| | - H J Wang
- Henan Cancer Hospital/Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
| | - Z J Wang
- State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - Z M Li
- Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China
| | - J Lin
- Department of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China
| | - Y F Guan
- Geneplus-Beijing, Beijing, China
| | - X F Xia
- Geneplus-Beijing, Beijing, China
| | - X Yi
- Geneplus-Beijing, Beijing, China
| | - Q Miao
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - B Wu
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - K Jiang
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - X B Zheng
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - W F Zhu
- Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - X L Zheng
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - P S Huang
- Department of Pathology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China
| | - W J Xiao
- Department of Pathology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China
| | - D Hu
- Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - L F Zhang
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - X R Fan
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| | - T S K Mok
- State Key Laboratory of Translational Oncology, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China.
| | - C Huang
- Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China
| |
Collapse
|
226
|
Zhou DW, Li ZM, Zhang SL, Wu L, Li YY, Zhou JX, Shi GZ. The optimal peripheral oxygen saturation may be 95-97% for post-cardiac arrest patients: A retrospective observational study. Am J Emerg Med 2020; 40:120-126. [PMID: 32001056 DOI: 10.1016/j.ajem.2020.01.038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Revised: 01/09/2020] [Accepted: 01/19/2020] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Current post-resuscitation guidelines recommend oxygen titration in adults with the return of spontaneous circulation after cardiac arrest. However, the optimal peripheral oxygen saturation (SpO2) is still unclear for post-cardiac arrest care. METHODS We conducted a retrospective observational study of prospectively collected data of all cardiac arrest patients admitted to the intensive care units between 2014 and 2015. The main exposure was SpO2, which were interfaced from bedside vital signs monitors as 1-min averages, and archived as 5-min median values. The proportion of time spent in different SpO2 categories was included in separate multivariable regression models along with covariates. The primary outcome measure was hospital mortality and the proportion of discharged home as the secondary outcome was reported. RESULTS 2836 post-cardiac arrest patients in ICUs of 156 hospitals were included. 1235 (44%) patients died during hospitalization and 818 (29%) patients discharged home. With multivariate regression analysis, the proportion of time spent in SpO2 of ≤89%, 90%, 91%, and 92% were associated with higher hospital mortality. The proportion of time spent in SpO2 of 95%, 96%, and 97% were associated with a higher proportion of discharged home outcome, but not associated with hospital mortality. CONCLUSIONS In this retrospective observational study, the optimal SpO2 for patients admitted to the intensive care unit after cardiac arrest may be 95-97%. Further investigation is warranted to determine if targeting SpO2 of 95-97% would improve patient-centered outcomes after cardiac arrest.
Collapse
Affiliation(s)
- D W Zhou
- Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Z M Li
- Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - S L Zhang
- Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - L Wu
- Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Y Y Li
- Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - J X Zhou
- Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - G Z Shi
- Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
| |
Collapse
|
227
|
Viquez MV, Wu L. Sensitivity and specificity of the red reflex in Costa Rican newborns. Arch Soc Esp Oftalmol (Engl Ed) 2020; 95:4-8. [PMID: 31826811 DOI: 10.1016/j.oftal.2019.10.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Revised: 10/06/2019] [Accepted: 10/20/2019] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To compare the results of indirect ophthalmoscopy versus determination of the red reflex in newborns admitted to the intermediate neonatal intensive care unit. METHODS All the patients (71) admitted to the intermediate neonatal intensive care unit from July to September of 2017 were screened with the red reflex. Immediately afterwards, they were pharmacologically dilated and indirect ophthalmoscopy was performed. All of the red-reflex screening and the funduscopic examination were performed by the same evaluator. RESULTS A total of 14.1% (20/142) of the eyes had an altered red reflex. Indirect ophthalmoscopy revealed that 21.8% (31/142) of the eyes had intraocular abnormalities. Two of these eyes had optic nerve colobomas, two eyes had cataracts, and the rest had intra-retinal haemorrhages. Indirect ophthalmoscopy revealed that only 35% (7/20) of the eyes with an altered red reflex had intraocular disease. Indirect ophthalmoscopy also revealed that intraocular disease was present in 77.4% (24/31) of the eyes despite a normal red reflex. The false positive rate of the red reflex was calculated to be 9.2%, and the false negative rate was 16.9%. The sensitivity of the red reflex was only 56.4%, and the specificity was 89.5%. The positive predictive value was 70.4%, and the negative predictive value was 82.2%. CONCLUSIONS Neonatal screening with the red reflex is not sufficient to detect intraocular disease. A normal neonatal red reflex does no exclude intraocular disease. It has a specificity of nearly 90%, but its sensitivity is only 56%. Most retinal haemorrhages are undiagnosed as they cannot be detected with a red reflex.
Collapse
Affiliation(s)
- M V Viquez
- Caja Costarricense del Seguro Social, San José, Costa Rica
| | - L Wu
- Asociados de Mácula, Vítreo y Retina de Costa Rica, San José, Costa Rica.
| |
Collapse
|
228
|
Abstract
BACKGROUND Recent studies have shown that hyperlipidemia is closely related to the progression of kidney disease and glomerulosclerosis has similar pathophysiological mechanisms with atherosclerosis. Atherosclerosis is essentially a chronic inflammatory process and various kidney diseases are characterized by a micro-inflammatory state. Hyperlipidemia levels are not parallel to the degree of glomerulosclerosis, inflammatory factors together with lipids may contribute to the pathogenesis of glomerulosclerosis. Therefore, it is key to clarify lipid-mediated renal injury through studying the mechanism by which inflammation affects cholesterol homeostasis at the cellular level. Intracellular lipid homeostasis involves both lipid uptake and excretion, therefore in this study, we aimed to explore whether interleukin-1β (IL-1β) promotes the uptake of oxidized low-density lipoprotein (Ox-LDL) to increase in intracellular lipid levels, and to clarify the effect of IL-1β on the expression of lectin-like oxidized LDL receptor 1 (LOX-1) and ATP-binding cassette transporter A1 (ABCA1), which may regulate cholesterol homeostasis in human mesangial cells (HMCs). METHODS The effect of IL-1β on uptake of Ox-LDL labeled with fluorescent Dil (Dil-Ox-LDL) by HMCs was observed using laser confocal microscopy. The effect of IL-1β on LOX-1 and ABCA1 expression in HMCs was detected by polymerase chain reaction and western blotting. RESULTS Laser confocal microscopy revealed that HMCs took up Dil-Ox-LDL. Treatment of HMCs with 5 ng/ml IL-1β for 24 h significantly increased uptake of Dil-Ox-LDL. IL-1β also promoted LOX-1 mRNA and protein expression in a dose-dependent manner. Moreover, ABCA1 mRNA and protein expression were reduced by IL-1β in lipid-loaded HMCs in a dose-dependent manner. CONCLUSIONS IL-1β promotes the uptake of Ox-LDL and expression of LOX-1 in HMCs, whereas it inhibits expression of ABCA1 under lipid load. The imbalance in intracellular cholesterol resulted by IL-1β can in turn transform HMCs into foam cells and aggravate glomerulosclerosis.
Collapse
Affiliation(s)
- H Liu
- Dr. Hua Liu, Department of Nephrology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China, e-mail: , Tel: +(86)18911651038; Dr. Lina Ma, Department of Geriatrics, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China, e-mail: , Tel: +(86)17600107787
| | | | | | | | | | | | | | | |
Collapse
|
229
|
Ma B, Wu L, Zhang W. Rare vascular ring of right aortic arch and aberrant left subclavian artery in association with bilateral ductus arteriosus. Ultrasound Obstet Gynecol 2020; 55:135-137. [PMID: 31162848 DOI: 10.1002/uog.20365] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Revised: 05/17/2019] [Accepted: 05/24/2019] [Indexed: 06/09/2023]
Affiliation(s)
- B Ma
- Department of Ultrasound, Gansu Provincial Maternity and Child-care Hospital, Gansu Province, China
| | - L Wu
- Department of Cardiology, Cardiovascular Center, Children's Hospital of Fudan University, Shanghai, China
| | - W Zhang
- Department of Pediatric Cardiology, Gansu Provincial Maternity and Child-care Hospital, Gansu Province, China
| |
Collapse
|
230
|
Hu YQ, Chen W, Yan MH, Lai JJ, Tang N, Wu L. Ischemic preconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PERK pathway. Eur Rev Med Pharmacol Sci 2019; 21:5736-5744. [PMID: 29272010 DOI: 10.26355/eurrev_201712_14020] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE The purpose of this study was to explore the effects of cerebral ischemic preconditioning which can decrease brain ischemia/reperfusion (I/R) injury by inhibiting endoplasmic reticulum (ER) stress-induced apoptosis. MATERIALS AND METHODS The focal cerebral ischemia rat was selected as the experimental model. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) positive cells in ischemic penumbra were assessed after cerebral reperfusion. We assessed terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) positive cells and measured the expressions of phosphorylation PERK (p-PERK), glucose-regulated protein 78 (GRP78), activating transcription factor-4 (ATF4) and caspase-12 in ischemic penumbra after cerebral reperfusion. RESULTS We showed that the infarct sizes can be reduced due to the preconditioning under the influence of brain ischemia after reperfusion. The effect of preconditioning on the expression of ER stress proteins suggested the expressions of the 4 proteins p-PERK, ATF4, caspase-12 and GRP78 in the penumbra cortex by immunohistochemistry and Western blot increased after cerebral ischemia. Significant reduction of the number of TUNEL-positive cells was in the penumbra cortex of the preconditioning group. CONCLUSIONS We found that cerebral ischemic preconditioning can protect the brain from I/R injury by inhibiting ER stress-induced apoptosis; the pathway of PERK is involved.
Collapse
Affiliation(s)
- Y-Q Hu
- Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
| | | | | | | | | | | |
Collapse
|
231
|
Wu L, Shen XF, Li Q, Chen WB. [A case of total deafness caused by traumatic pneumolabyrinth]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2019; 54:928-930. [PMID: 31887820 DOI: 10.3760/cma.j.issn.1673-0860.2019.12.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Affiliation(s)
- L Wu
- Department of Otorhinolaryngology, the Affiliated Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| | - X F Shen
- Department of Otorhinolaryngology, the Affiliated Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| | - Q Li
- Department of Otorhinolaryngology, the Affiliated Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| | - W B Chen
- Department of Otorhinolaryngology, the Affiliated Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| |
Collapse
|
232
|
Huang Z, Li N, Liu J, Hou Y, Wang L, Zhan S, Wu L, Wang Y. Nocturnal heart rate variability as a biomarker for autonomic nervous system dysfunction in fatal familial insomnia. Sleep Med 2019. [DOI: 10.1016/j.sleep.2019.11.447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
233
|
Griffis H, Wu L, Naim MY, Bradley R, Tobin J, McNally B, Vellano K, Quan L, Markenson D, Rossano JW. Characteristics and outcomes of AED use in pediatric cardiac arrest in public settings: The influence of neighborhood characteristics. Resuscitation 2019; 146:126-131. [PMID: 31785372 DOI: 10.1016/j.resuscitation.2019.09.038] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2019] [Revised: 08/27/2019] [Accepted: 09/09/2019] [Indexed: 01/17/2023]
Abstract
BACKGROUND Automated external defibrillators (AEDs) are critical in the chain of survival following out-of-hospital cardiac arrest (OHCA), yet few studies have reported on AED use and outcomes among pediatric OHCA. This study describes the association between bystander AED use, neighborhood characteristics and survival outcomes following public pediatric OHCA. METHODS Non-traumatic OHCAs among children less than18 years of age in a public setting between from January 1, 2013 through December 31, 2017 were identified in the CARES database. A neighborhood characteristic index was created from the addition of dichotomous values of 4 American Community Survey neighborhood characteristics at the Census tract level: median household income, percent high school graduates, percent unemployment, and percent African American. Multivariable logistic regression models assessed the association of OHCA characteristics, the neighborhood characteristic index and outcomes. RESULTS Of 971 pediatric OHCA, AEDs were used by bystanders in 10.3% of OHCAs. AEDs were used on 2.3% of children ≤1 year (infants), 8.3% of 2-5 year-olds, 12.4% of 6-11 year-olds, and 18.2% of 12-18 year-olds (p < 0.001). AED use was more common in neighborhoods with a median household income of >$50,000 per year (12.3%; p = 0.016), <10% unemployment (12.1%; p = 0.002), and >80% high school education (11.8%; p = 0.002). Greater survival to hospital discharge and neurologically favorable survival were among arrests with bystander AED use, varying by neighborhood characteristics. CONCLUSIONS Bystander AED use is uncommon in pediatric OHCA, particularly in high-risk neighborhoods, but improves survival. Further study is needed to understand disparities in AED use and outcomes.
Collapse
Affiliation(s)
- H Griffis
- Healthcare Analytics Unit, The Children's Hospital of Philadelphia, United States; Department of Biomedical Health Informatics, The Children's Hospital of Philadelphia, United States; Cardiac Center Research Core, The Children's Hospital of Philadelphia, United States.
| | - L Wu
- The Children's Hospital of Philadelphia, United States
| | - M Y Naim
- Cardiac Center Research Core, The Children's Hospital of Philadelphia, United States; The Children's Hospital of Philadelphia, United States; Division of Critical Care, The Children's Hospital of Philadelphia, United States
| | - R Bradley
- Division of Emergency Medical Services and Disaster Medicine, University of Texas Health Science Center, United States
| | - J Tobin
- Division of Trauma Anesthesiology, University of Southern California, United States
| | - B McNally
- Department of Emergency Medicine, Emory University, United States
| | - K Vellano
- Department of Emergency Medicine, Emory University, United States
| | - L Quan
- Division of Pediatric Emergency Medicine, Department of Pediatrics, University of Washington School of Medicine, United States
| | | | - J W Rossano
- Cardiac Center Research Core, The Children's Hospital of Philadelphia, United States; The Children's Hospital of Philadelphia, United States; Division of Critical Care, The Children's Hospital of Philadelphia, United States
| | | |
Collapse
|
234
|
Wu L, Liao HR, Hu YL, Li WF, Zhu CC, Li GQ, Wang XL, Chen PA. [The analysis of health effects of exposure to occupational hazards on works in gypsum mining enterprise]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2019; 37:793-796. [PMID: 31726515 DOI: 10.3760/cma.j.issn.1001-9391.2019.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the health of gypsum miners in Hubei province and analyze the health effects of occupational disease hazards exposure on gypsum miners. Methods: In April 2017, occupational disease hazard factors were tested on the site of a gypsum mine, and 500 workers were selected by random sampling to conduct questionnaires, relevant data such as occupational health examination was collected, and descriptive statistical analysis was performed. Results: The main occupational hazards of gypsum miners were gypsum dust and noise. The time-weighted average concentration of 8 h in the workplace was 4.32 to 9.34 mg/m(3), and the post pass rate was 69.2% (9/13) ; Respiratory dust 0.13-5.15 mg/m(3), post pass rate 75.0% (3/4). Gypsum miners had finger dysfunction and muscle numbness, joint pain (29.2%, 88/301) and chest pain and breathing difficulties (17.6%, 53/301). Followed by tinnitus, auricle pus, running water (4.7%, 14/301), abnormal muscle tension (2.7%, 8/301). The exposure of occupational disease hazards was associated with respiratory, auditory and neurological symptoms of gypsum miners. Conclusion: The long-term exposure of gypsum workers to gypsum dust, noise and other harmful factors may result in obvious symptoms of respiratory system and other health damage.
Collapse
Affiliation(s)
- L Wu
- Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Department of Clinical Medicine, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China
| | - H R Liao
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - Y L Hu
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - W F Li
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - C C Zhu
- Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan 430065, China
| | - G Q Li
- Yingcheng Center for Disease Control and Prevention, Yingcheng 432400, China
| | - X L Wang
- Yingcheng Center for Disease Control and Prevention, Yingcheng 432400, China
| | - P A Chen
- Yingcheng Center for Disease Control and Prevention, Yingcheng 432400, China
| |
Collapse
|
235
|
Zhang X, Wang A, Zhang J, Singh M, Liu D, Zuo Y, Wu L, Song M, Wang W, Feigin V, Wang Y, Zheng D. Association of plasma C-reactive protein with ischaemic stroke: a Mendelian randomization study. Eur J Neurol 2019; 27:565-571. [PMID: 31692152 DOI: 10.1111/ene.14113] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Accepted: 11/04/2019] [Indexed: 12/30/2022]
Abstract
BACKGROUND AND PURPOSE Elevated C-reactive protein (CRP) is associated with an increased risk of ischaemic stroke (IS). However, the causality of this association is uncertain. The aim is to investigate whether genetically raised plasma CRP concentration levels are associated with IS on the basis of the Mendelian randomization method. METHODS Based on the National Center for Biotechnology Information single nucleotide polymorphism (SNP) database, the Chinese online genetic database as well as previously published studies, four CRP-associated SNP alleles (rs1130864, rs1205, rs876537 and rs3093059) with minor allele frequency ≥0.15 were selected and the concentration levels of CRP were measured in 378 first-ever IS patients and 613 healthy controls. RESULTS Three SNPs were chosen and used as instrumental variables. The adjusted odds ratios (ORs) [95% confidence interval (95% CI)] of IS per addition of the modelled allele were 1.07 (0.79-1.45) for rs876537, 0.99 (0.73-1.35) for rs1205 and 1.08 (0.71-1.65) for rs3093059. The OR (95% CI) of IS for plasma CRP ≥2.0 mg/l was 2.19 (1.06-4.53) compared with <2.0 mg/l. The adjusted OR (95% CI) of IS per genetically predicted 10% higher CRP concentration, based on the three SNPs as the instruments, was 1.02 (0.94-1.11). Furthermore, similar results were obtained with adjusted ORs (95% CI) of 1.00 (0.88-1.13) and 1.04 (0.93-1.16), respectively, for large-artery atherosclerosis and small-artery occlusion per genetically predicted 10% higher CRP concentration. CONCLUSIONS This Mendelian randomization study provides no clear support that elevated CRP concentration is causally associated with the risk of IS.
Collapse
Affiliation(s)
- X Zhang
- Department of Epidemiology and Health Statistics, School of Public Health, Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China
| | - A Wang
- China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - J Zhang
- Department of Epidemiology and Health Statistics, School of Public Health, Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China
| | - M Singh
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia
| | - D Liu
- Department of Epidemiology and Health Statistics, School of Public Health, Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China
| | - Y Zuo
- China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - L Wu
- Department of Epidemiology and Health Statistics, School of Public Health, Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China
| | - M Song
- Department of Epidemiology and Health Statistics, School of Public Health, Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China
| | - W Wang
- School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia
| | - V Feigin
- National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
| | - Y Wang
- Department of Epidemiology and Health Statistics, School of Public Health, Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China
| | - D Zheng
- Department of Epidemiology and Health Statistics, School of Public Health, Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, Beijing, China
| |
Collapse
|
236
|
Wan K, Li Y, Sun W, An R, Tang Z, Wu L, Chen H, Sun Z. Effects of dietary calcium pyruvate on gastrointestinal tract development, intestinal health and growth performance of newly weaned piglets fed low-protein diets. J Appl Microbiol 2019; 128:355-365. [PMID: 31618501 DOI: 10.1111/jam.14494] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2019] [Revised: 09/24/2019] [Accepted: 10/06/2019] [Indexed: 12/28/2022]
Abstract
AIM This study was carried out to investigate the effects of dietary calcium pyruvate supplementation on growth performance and intestinal health of weaned piglets fed low-protein diets. METHODS AND RESULTS After a 7-day adaptation period, 60 individually housed piglets (Duroc × Yorkshire-Landrace) weaned at 28 days of age were randomly assigned to receive one of three treatments (20 pigs/treatment) for 28 days: control diet (20·0% crude protein [CP]), low-protein diet (15·5% CP), and experimental (15·5% CP + 1·8% calcium pyruvate). At the end of the experiment, six piglets from each diet group were slaughtered and blood and tissue samples were collected. Compared with the control group, feeding piglets with 15·5% CP decreased the daily body weight gain; lengths of the duodenum, jejunum and ileum; and weights of the stomach, duodenum, jejunum and ileum (P < 0·05), while 15·5% CP + 1·8% calcium pyruvate supplementation removed those differences (P > 0·05). Compared with the control group, the diarrhoea incidence and relative richness of Firmicutes in the colon contents of piglets in both the 15·5% CP and 15·5% CP + 1·8% calcium pyruvate groups was decreased. The relative richness of Bacteriodetes in the colon contents of piglets was higher in the 15·5% CP + 1·8% calcium pyruvate group than in the control and 15·5% CP groups (P < 0·05). CONCLUSION Calcium pyruvate supplementation for four weeks removed the negative effects of a low-protein diet on the gastrointestinal tract development and daily body weight gain of weaned piglets. SIGNIFICANCE AND IMPACT OF THE STUDY This study showed that supplementing a low-protein diet with calcium pyruvate, an effective alternative metabolic fuel to amino acids, was beneficial in improving the intestinal health and maximizing the growth of newly weaned piglets.
Collapse
Affiliation(s)
- K Wan
- Laboratory of Bio-feed and Molecular Nutrition, Southwest University, Chongqing, P. R. China
| | - Y Li
- Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu, P. R. China
| | - W Sun
- Laboratory of Bio-feed and Molecular Nutrition, Southwest University, Chongqing, P. R. China
| | - R An
- Laboratory of Bio-feed and Molecular Nutrition, Southwest University, Chongqing, P. R. China
| | - Z Tang
- Laboratory of Bio-feed and Molecular Nutrition, Southwest University, Chongqing, P. R. China
| | - L Wu
- Laboratory of Bio-feed and Molecular Nutrition, Southwest University, Chongqing, P. R. China
| | - H Chen
- Laboratory of Bio-feed and Molecular Nutrition, Southwest University, Chongqing, P. R. China
| | - Z Sun
- Laboratory of Bio-feed and Molecular Nutrition, Southwest University, Chongqing, P. R. China
| |
Collapse
|
237
|
Cheng Y, Zhang L, Hu J, Wang D, Hu C, Zhou J, Wu L, Cao L, Liu J, Zhang H, Sun H, Wang Z, Gao H, Ge J, Wang H, Tian Y, Piperdi B, Paz-Ares L. Keynote-407 China Extension study: Pembrolizumab (pembro) plus chemotherapy in Chinese patients with metastatic squamous NSCLC. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz446.019] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
238
|
Li Y, Chen Z, Wu L, Tao W. Novel tumour mutation score versus tumour mutation burden in predicting survival after immunotherapy in pan-cancer from MSK-IMPACT cohort. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz438.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
239
|
Zhu Z, Wu L, Ding J, Hua K. 1489 Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Accelerate Growth of VK2 Vaginal Epithelial Cells through Micrornas In Vitro. J Minim Invasive Gynecol 2019. [DOI: 10.1016/j.jmig.2019.09.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
240
|
Carswell A, Gongadze K, Misselbrook T, Wu L. Impact of transition from permanent pasture to new swards on the nitrogen use efficiency, nitrogen and carbon budgets of beef and sheep production. Agric Ecosyst Environ 2019; 283:106572. [PMID: 31680709 PMCID: PMC6694753 DOI: 10.1016/j.agee.2019.106572] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Abstract
There is currently much debate around the environmental implications of ruminant farming and a need for robust data on nitrogen (N) and carbon (C) fluxes from beef and sheep grazing systems. Here we use data collected from the North Wyke Farm Platform along with the SPACSYS model to examine the N and C budgets and the N use efficiency (NUE) of grassland swards at different stages of establishment. We assessed the transition from permanent pasture (PP) to a high-sugar grass (HSG), and a mixed sward of HSG with white clover (HSGC), identifying data specifically for the reseed (RS) years and the first year following RS (HSG-T and HSGC-T). Dominant fluxes for the N budget were N offtake as cut herbage and via livestock grazing, chemical-N fertiliser and N leaching at 88-280, 15-177, and 36-92 kg N ha-1 a-1, respectively. Net primary productivity, soil respiration and C offtake as cut herbage and via livestock grazing at 1.9-15.9, 1.74-12.5, and 0.34-11.7 t C ha-1 a-1, respectively, were the major C fluxes. No significant differences were found between the productivity of any of the swards apart from in the RS year of establishment. However, NUE of the livestock production system was significantly greater for the HSGC and HSGC-T swards at 32 and 42% compared to all other swards, associated with the low chemical-N fertiliser inputs to these clover-containing swards. Our findings demonstrate opportunities for improving NUE in grazing systems, but also the importance of setting realistic NUE targets for these systems to provide achievable goals for land-managers.
Collapse
|
241
|
Wu L, Zhu J, Yin R, Wu X, Lou G, Wang J, Gao Y, Kong B, Lu X, Zhou Q, Wang Y, Chen Y, Lu W, Li W, Cheng Y, Liu J, Ma X, Zhang J. Olaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz426.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
242
|
Wu L, Chen H, Li X, Zhu Y, Du K, Wang W, Xu C. EP1.16-33 QT Prolongation in an EGFR 19 Deletion Lung Adenocarcinoma Patient from Icotinib Treatment. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2398] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
243
|
Li Y, Chen Z, Wu L, Tao W. JCSE01.19 Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
244
|
Wu L, Cao L, Chen L, Zhu B, Hu X, Lin G, Lin Y, Zhang S, Peng W, Jiang M, Mao X, Zhang T, Ye J, Zhang L. OA03.05 Characterization of Genomic Alterations in Chinese LCNEC and SCLC via Comprehensive Genomic Profiling. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
245
|
Cheng Y, Wang Q, Li K, Shi J, Liu Y, Wu L, Han B, Chen G, He J, Wang J, Lou D, Yu H, Qin H, Li XL. Overall survival (OS) update in ALTER 1202: Anlotinib as third-line or further-line treatment in relapsed small-cell lung cancer (SCLC). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz264.002] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
246
|
Shi YK, Zhang S, Hu X, Feng J, Ma Z, Zhou J, Yang N, Wu L, Liao W, Han X, Wang Z, Zhang X, Qin S, Ying K, Feng J, Fang J, Liu L, Jiang Y. Safety and activity of alflutinib in patients with advanced EGFR T790M mutation non-small cell lung cancer who progressed after EGFR-TKI therapy. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz260.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
247
|
Wu YL, Liu SY, Wang Q, Mao W, Wu L, Shen Y, Cheng Y, Chen C, Xu L, Wang J, Liu HX, Bao H, Chen YD, Zhang X, Chen ZH, Yan HH, Yang JJ, Shao Y, Zhou Q, Zhong WZ. A comprehensive model of genetic-features predicts outcome of personalized adjuvant treatment in resected EGFR-mutant stage II-IIIA NSCLC: Results from a phase III trial (CTONG 1104-ADJUVANT). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz258.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
248
|
Li K, Cheng Y, Wang Q, Shi J, Han B, Wu L, Chen G, He J, Wang J, Qin H, Li X. P2.12-11 Quality of Life in ALTER1202 Trial of Anlotinib as Third-or Further Line Therapy for Advanced Small Cell Lung Cancer (SCLC): A Post-Hoc Analysis. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
249
|
Wu L, Cao L, Chen L, Zhu B, Hu X, Lin G, Lin Y, Zhang S, Peng W, Jiang M, Mao X, Zhang T, Ye J, Zhang L. EP1.12-10 Molecular Characterization of NSCLC-Like and SCLC-Like Subsets in Chinese Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
250
|
Wang Q, Cheng Y, Li K, Shi J, Han B, Wu L, Chen G, He J, Wang J, Qin H, Li X. OA03.02 Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|